New review points to faster, safer vaccine development
Short excerpt below. Click through to read at the original source.
Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa’s focus on increasing its vaccine manufacturing, and pandemic preparedness.